CLU and type 2 diabetes mellitus: The serum level of ApoJ level was found to be significantly increased in type II diabetes patients and in patients with either a developing coronary heart disease or myocardial infarction as compared to healthy individuals, but its level showed no correlation with the number of vessels with documented atherosclerotic damage [18, 19].